Alnylam Pharmaceuticals, Inc. (ALNY): R&D Expense
$1.32B
Year ended 2025-12-31
$1.51B
Trailing 12 months to 2026-06-30
+14.3%
3-year compound annual growth
+15.0%
5-year compound annual growth
+16.9%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.32B | +17.2% | 2026-02-12, From 2025-01-01 |
| 2024-12-31 | $1.13B | +12.1% | 2026-02-12, From 2024-01-01 |
| 2023-12-31 | $1.00B | +13.7% | 2026-02-12, From 2023-01-01 |
| 2022-12-31 | $883.01M | +11.5% | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | $792.16M | +21.0% | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | $654.82M | 0.0% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $655.11M | +29.6% | 2022-02-10, From 2019-01-01 |
| 2018-12-31 | $505.42M | +29.4% | 2021-02-11, From 2018-01-01 |
| 2017-12-31 | $390.63M | +2.2% | 2020-02-13, From 2017-01-01 |
| 2016-12-31 | $382.39M | +38.3% | 2019-02-14, From 2016-01-01 |
| 2015-12-31 | $276.50M | +45.3% | 2018-02-15, From 2015-01-01 |
| 2014-12-31 | $190.25M | +68.4% | 2017-02-15, From 2014-01-01 |
| 2013-12-31 | $112.96M | +30.5% | 2016-02-12, From 2013-01-01 |
| 2012-12-31 | $86.57M | -12.8% | 2015-02-13, From 2012-01-01 |
| 2011-12-31 | $99.30M | -6.7% | 2014-02-20, From 2011-01-01 |
| 2010-12-31 | $106.38M | -2.2% | 2013-02-19, From 2010-01-01 |
| 2009-12-31 | $108.73M | +12.2% | 2012-02-13, From 2009-01-01 |
| 2008-12-31 | $96.88M | n/a | 2011-02-18, From 2008-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $1.32B | +17.2% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $95.40M | -15.0% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $782.74M | -11.5% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $921.93M | +23.4% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $550.00M | +14.3% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $186.18M | -2.4% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $368.00M | +7.0% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $2.15B | +9.9% |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $452.00M | n/m |
Compare ALNY, PRGO, JAZZ, BMRN side by side · Screen every company in Pharmaceutical Preparations ↗